Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Jaipur Smart City Limited selects SoftTech Engineers Limited for end-to-end implementation of Works Information Management System Press Release
  • Matix Chairman Nishant Kanodia sees eastern India as country’s fertilizer demand growth engine Business
  • Tanishq Joshi Dancer Spotlight: 10 Campaigns That Redefined the Stage Entertainment
  • DrWheelz Auto Solutions Announces Launch of Operations in Thiruvananthapuram Business
  • Flipkart Elevates Ankit Agarwal to Vice President, Business Finance Business
  • Poornima Yadav Shines as Mrs. India World 2024 First Runner- Up – A Journey of Strength and Determination Lifestyle
  • BigBloc Construction Ltd recommends 1:1 Bonus Issue Business
  • How Inflation and Medical Costs Are Influencing Health Insurance Premiums Health

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • Narayana One Health Partners with dacadoo to Launch the One Health Score Health
  • Seraseal, World’s Most Advanced, Next Generation Hemostatic Technology, Now In India! Health
  • Lung Cancer Day: Early Detection & Insights from Leading Experts Health
  • SBI Foundation MD Sanjay Prakash and Dr. Dharmendra Kumar Join TB-Free Maha Arogya Shivir Health
  • Introducing Constishain: The Ayurvedic Breakthrough for Natural Constipation Relief Health
  • Sarvodaya Hospital, Faridabad, brings North India’s First Hip Navigation Technology for Hip Replacement Surgeries Health

Recent Posts

  • From Udgir to the Himalayas: Dr. Kiran Vemuri Conquers Mera Peak Against All Odds
  • VMS TMT Limited Approves Amalgamation with Aditya Ultra Steel Limited
  • HSBC Announces Plans for Integrated Campus in Bengaluru
  • Cupid Limited Poised to Deliver Revenue Exceeding ₹150 Cr in Q1 FY27; Management Revises Medium-Term Growth Outlook Upwards
  • The Dentist Brings Cashless Dental Treatment to Electronic City, Bengaluru — Now Accepting MediBuddy Insurance Across 3 Branches

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Kingston Technology Remains Top DRAM Module Supplier for 2020 Business
  • Regional Skill Development and Certification Authority (RSDCA) is a tool to help you reach your goals, no matter what is holding you back! Growing Online Skill Assessment and Certification Agency Business
  • From Small-Town India to AI Innovation: Neeraj Bansal, BeSpoke AI Stylist, Built a Startup Without External Funding Business
  • Sachin Patil, MD & CEO of Messe Stuttgart India Applauds Union Budget 2024’s Infrastructure Boost for Exhibition and MICE Industry Finance
  • RedMonk Wellness announced House of Hydration​ with Doorstep IV drips Business
  • India’s Judicial Fraternity Comes Together for a Historic Badminton Championship in Delhi Sports
  • Empower India Limited Expands into Digital Solar Solutions to Capture India’s Fast-Growing Renewable Energy Market Business
  • Hasley India Originals’ founder Ankit Madaan promises a double bonanza for all its viewers and fans Entertainment

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme